The Common MiRNAs Between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review

Overview

Journal Tanaffos

Specialty Pulmonary Medicine

Date 2022 Apr 6

PMID 35382078

Authors

Mojgan Sheikhpour

Hanie Abolfathi

Morteza Karimipoor

Abolfazl Movafagh

Mahbubeh Shahsavani

Affiliations

Soon will be listed here.

Abstract

Tuberculosis (TB) and non-small cell lung cancer (NSCLC) are two major contributors to mortality and morbidity worldwide. In this regard, TB and NSCLC have similar symptoms, and TB has symptoms that are identical to malignancy; therefore, sometimes it is mistakenly diagnosed as lung cancer. Moreover, patients with active pulmonary TB are at a higher risk of dying due to lung cancer. In addition, several signaling pathways involved in TB and NSCLC have been identified. Also, the miRNAs are biological molecules shown to play essential roles in the above-mentioned diseases through targeting the signaling pathways' genes. Most of the pathways affected by miRNAs are immune responses such as autophagy and apoptosis in TB and NSCLC, respectively. Several studies have separately investigated the expression of miRNAs profile in patients with NSCLC and infectious TB. In this critical review, we attempted to gather common miRNAs between TB and NSCLC and to explain the involved-pathways, which are affected by miRNAs in both TB and NSCLC. Results of this critical review show that the expressions of miR-155, miR-146a, miR-125b, miR-30a, miR-29a, and miR-Let7 have significantly changed in TB and NSCLC. The data suggest that miRNAs expression may provide a new method for screening or differential diagnosis of NSCLC and TB.

References

Yang Y, Li H, Liu Y, Chi C, Ni J, Lin X . MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability. Biomed Pharmacother. 2019; 115:108956. DOI: 10.1016/j.biopha.2019.108956. View

Yan H, Wang W, Du X, Jiang X, Lin C, Guo J . The expression and clinical significance of miRNA-99a and miRNA-224 in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019; 23(4):1545-1552. DOI: 10.26355/eurrev_201902_17113. View

Wang R, Zheng Y, Wang P, Zhang J . Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol. 2015; 8(1):765-71. PMC: 4348919. View

Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J . MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer. 2011; 130(9):2044-53. DOI: 10.1002/ijc.26218. View

Esraah Alharris , Singh N, Nagarkatti P, Nagarkatti M . Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019; 10(1):45-59. PMC: 6343753. DOI: 10.18632/oncotarget.26534. View

Xie Y, Zhao F, Zhang P, Duan P, Shen Y . miR-29b inhibits non-small cell lung cancer progression by targeting STRN4. Hum Cell. 2019; 33(1):220-231. DOI: 10.1007/s13577-019-00305-w. View

Dong J, Zhang Z, Gu T, Xu S, Dong L, Li X . The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer. Onco Targets Ther. 2017; 10:185-194. PMC: 5207466. DOI: 10.2147/OTT.S116619. View

Li C, Yin Y, Liu X, Xi X, Xue W, Qu Y . Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance. Oncotarget. 2017; 8(15):24564-24578. PMC: 5421870. DOI: 10.18632/oncotarget.15596. View

Rajaram M, Ni B, Morris J, Brooks M, Carlson T, Bakthavachalu B . Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A. 2011; 108(42):17408-13. PMC: 3198317. DOI: 10.1073/pnas.1112660108. View

10.

Wang M, Zhu X, Sha Z, Li N, Li D, Chen L . High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients. Br J Cancer. 2015; 112(5):874-82. PMC: 4453958. DOI: 10.1038/bjc.2015.3. View

11.

Wang M, Xu G, Lu L, Xu K, Chen Y, Pan H . Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis. Sci Rep. 2016; 6:28586. PMC: 4919632. DOI: 10.1038/srep28586. View

12.

Wang Y, Xu Y, Zou Y, Lin J, Huang B, Liu J . Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions. Medicine (Baltimore). 2017; 96(44):e8361. PMC: 5682784. DOI: 10.1097/MD.0000000000008361. View

13.

Xia H, Xiu M, Gao J, Jing H . LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival. BMC Pulm Med. 2019; 19(1):172. PMC: 6734259. DOI: 10.1186/s12890-019-0931-6. View

14.

Chen Z, Wang T, Liu Z, Zhang G, Wang J, Feng S . Inhibition of Autophagy by MiR-30A Induced by Mycobacteria tuberculosis as a Possible Mechanism of Immune Escape in Human Macrophages. Jpn J Infect Dis. 2015; 68(5):420-4. DOI: 10.7883/yoken.JJID.2014.466. View

15.

Hu Z, Cui Y, Zhou Y, Zhou K, Qiao X, Li C . MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1. Onco Targets Ther. 2016; 9:6999-7009. PMC: 5117897. DOI: 10.2147/OTT.S116509. View

16.

Zhang B, Pan X, Cobb G, Anderson T . microRNAs as oncogenes and tumor suppressors. Dev Biol. 2006; 302(1):1-12. DOI: 10.1016/j.ydbio.2006.08.028. View

17.

Hoballa M, Soltani B, Mowla S, Sheikhpour M, Kay M . Identification of a novel intergenic miRNA located between the human DDC and COBL genes with a potential function in cell cycle arrest. Mol Cell Biochem. 2017; 444(1-2):179-186. DOI: 10.1007/s11010-017-3242-3. View

18.

Iacona J, Monteleone N, Lutz C . miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells. Oncotarget. 2018; 9(42):26751-26769. PMC: 6003571. DOI: 10.18632/oncotarget.25482. View

19.

Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K . The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol. 2013; 43(8):813-20. DOI: 10.1093/jjco/hyt084. View

20.

Wagh V, Urhekar A, Modi D . Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy. Tuberculosis (Edinb). 2017; 102:24-30. DOI: 10.1016/j.tube.2016.10.007. View